- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 19/00 - Drugs for skeletal disorders
Patent holdings for IPC class A61P 19/00
Total number of patents in this class: 2561
10-year publication summary
|
113
|
135
|
99
|
123
|
126
|
127
|
156
|
174
|
127
|
46
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 11238 |
34 |
| Takeda Pharmaceutical Company Limited | 2961 |
27 |
| Daiichi Sankyo Company, Limited | 1829 |
21 |
| The Regents of the University of California | 18943 |
20 |
| Janssen Pharmaceutica N.V. | 3839 |
19 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
18 |
| Boehringer Ingelheim International GmbH | 4629 |
16 |
| Osaka University | 3143 |
16 |
| Bristol-myers Squibb Company | 5080 |
15 |
| AstraZeneca AB | 3042 |
15 |
| Kyoto University | 2732 |
14 |
| Pfizer Inc. | 3322 |
13 |
| Warsaw Orthopedic, Inc. | 3184 |
13 |
| Seoul National University R&db Foundation | 2976 |
13 |
| Société des Produits Nestlé S.A. | 9672 |
12 |
| Galapagos NV | 304 |
12 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
12 |
| Medivir AB | 142 |
12 |
| Rigel Pharmaceuticals, Inc. | 613 |
12 |
| The Johns Hopkins University | 5377 |
11 |
| Other owners | 2236 |